22902290 Ultraviolet-visible Reference Spectra JP XVII Droxidopa

Dydrogesterone

Ebastine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 22912291 Ecabet Sodium Hydrate

Edaravone

Edrophonium Chloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 22922292 Ultraviolet-visible Reference Spectra JP XVII Elcatonin

Emedastine Fumarate

Emorfazone

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 22932293 Enoxacin Hydrate

Enviomycin Sulfate

Epalrestat

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 22942294 Ultraviolet-visible Reference Spectra JP XVII Eperisone Hydrochloride

Ephedrine Hydrochloride

Epirizole

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 22952295 Epirubicin Hydrochloride

Eplerenone

Estazolam

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 22962296 Ultraviolet-visible Reference Spectra JP XVII Estriol

Etacrynic Acid

Ethenzamide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 22972297 Ethionamide

Ethosuximide

Ethyl Icosapentate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 22982298 Ultraviolet-visible Reference Spectra JP XVII Ethylmorphine Hydrochloride Hydrate

Etilefrine Hydrochloride

Etizolam

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 22992299 Etodolac

Etoposide

Famotidine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 23002300 Ultraviolet-visible Reference Spectra JP XVII Felbinac

Fenbufen

Fentanyl Citrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 23012301 Fexofenadine Hydrochloride

Flavoxate Hydrochloride

Flecainide Acetate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 23022302 Ultraviolet-visible Reference Spectra JP XVII Flomoxef Sodium

Flopropione

Fluconazole

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 23032303 Flucytosine

Fludiazepam 1

Fludiazepam 2

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 23042304 Ultraviolet-visible Reference Spectra JP XVII Fludrocortisone Acetate

Flunitrazepam

Fluocinonide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 23052305 Fluorometholone

Fluorouracil

Fluoxymesterone

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 23062306 Ultraviolet-visible Reference Spectra JP XVII Fluphenazine Enanthate

Flurazepam Hydrochloride

Flurbiprofen

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 23072307 Flutamide

Flutoprazepam

Fluvoxamine Maleate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 23082308 Ultraviolet-visible Reference Spectra JP XVII Folic Acid

Formoterol Fumarate Hydrate

Furosemide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 23092309 Gabexate Mesilate

b-Galactosidase (Aspergillus)

Glibenclamide

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 23102310 Ultraviolet-visible Reference Spectra JP XVII Gliclazide

Glimepiride

Gonadorelin Acetate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 23112311 Gramicidin

Guaifenesin

Guanabenz Acetate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 23122312 Ultraviolet-visible Reference Spectra JP XVII Haloperidol

Haloxazolam

Homochlorcyclizine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 23132313 Hydralazine Hydrochloride

Hydrochlorothiazide

Hydrocotarnine Hydrochloride Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 23142314 Ultraviolet-visible Reference Spectra JP XVII Hydroxocobalamin Acetate

Hydroxyzine Hydrochloride

Hydroxyzine Pamoate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 23152315 Hymecromone

Ibudilast

Ibuprofen

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 23162316 Ultraviolet-visible Reference Spectra JP XVII Ibuprofen Piconol

Idarubicin Hydrochloride

Idoxuridine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 23172317 Ifenprodil Tartrate

Imipenem Hydrate

Imipramine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 23182318 Ultraviolet-visible Reference Spectra JP XVII Indapamide

Indenolol Hydrochloride 1

Indenolol Hydrochloride 2

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 23192319 Indigocarmine

Indometacin

Iohexol

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 23202320 Ultraviolet-visible Reference Spectra JP XVII Ipratropium Bromide Hydrate

Ipriflavone

Irbesartan

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 23212321 Irsogladine Maleate

Isoniazid

l-Isoprenaline Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 23222322 Ultraviolet-visible Reference Spectra JP XVII Isoxsuprine Hydrochloride

Itraconazole

Josamycin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 23232323 Josamycin Propionate

Ketamine Hydrochloride

Ketoconazole

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 23242324 Ultraviolet-visible Reference Spectra JP XVII Ketoprofen

Ketotifen Fumarate

Kitasamycin

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 23252325 Kitasamycin Acetate

Kitasamycin Tartrate

Labetalol Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 23262326 Ultraviolet-visible Reference Spectra JP XVII Lafutidine

Lansoprazole

Latamoxef Sodium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 23272327 Levallorphan Tartrate

Levodopa

Levofloxacin Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 23282328 Ultraviolet-visible Reference Spectra JP XVII Levothyroxine Sodium Hydrate

Lidocaine

Limaprost Alfadex

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 23292329 Liothyronine Sodium

Lisinopril Hydrate

Lobenzarit Sodium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 23302330 Ultraviolet-visible Reference Spectra JP XVII Lorazepam

Losartan Potassium

Loxoprofen Sodium Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 23312331 Lysozyme Hydrochloride

Manidipine Hydrochloride

Maprotiline Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)